REGNON
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion.
Nombre REGNON
Puesto No.3673
Cap. de mercado $13.55K
Cap. de mercado totalmente diluida $13.55K
Cuota de mercado %
Vol. de operaciones/Cap. de mercado (24 h) 1,751,686.85%
Suministro de circulación 14.26
Suministro máx. 0
Suministro total 14.26206345
Tasa de circulación %
Fecha de emisión --
El precio al que el activo fue emitido por primera vez --
Máximo histórico 1000.4620892596903, 2026-11-04
Precio más bajo 595.2849688688211, 2026-06-02
Blockchain pública REGNON
Introducción Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion.
Sector
- common.mc-trade-zone-xStocks
Redes sociales
Análisis de flujo de fondos
|
Comprar(REGNON) |
Vender(REGNON) |
Ingresos netos |
| Grande |
0.000 |
0.000 |
0.000 |
| Mediana |
0.000 |
0.000 |
0.000 |
| Pequeña |
0.267 |
0.000 |
0.267 |
| Total |
0.267 |
0.000 |
0.267 |
Aviso de riesgos: Los datos proporcionados por cmc no deben considerarse como asesoramiento de inversión.